These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32341059)

  • 1. Cullin 3 Is Crucial for Pro-B Cell Proliferation, Interacts with CD22, and Controls CD22 Internalization on B Cells.
    Meyer SJ; Böser A; Korn MA; Koller C; Bertocci B; Reimann L; Warscheid B; Nitschke L
    J Immunol; 2020 Jun; 204(12):3360-3374. PubMed ID: 32341059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD22 Controls Germinal Center B Cell Receptor Signaling, Which Influences Plasma Cell and Memory B Cell Output.
    Meyer SJ; Steffensen M; Acs A; Weisenburger T; Wadewitz C; Winkler TH; Nitschke L
    J Immunol; 2021 Aug; 207(4):1018-1032. PubMed ID: 34330755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.
    Spiller F; Nycholat CM; Kikuchi C; Paulson JC; Macauley MS
    J Immunol; 2018 Feb; 200(3):949-956. PubMed ID: 29288201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.
    Matsubara N; Imamura A; Yonemizu T; Akatsu C; Yang H; Ueki A; Watanabe N; Abdu-Allah H; Numoto N; Takematsu H; Kitazume S; Tedder TF; Marth JD; Ito N; Ando H; Ishida H; Kiso M; Tsubata T
    Front Immunol; 2018; 9():820. PubMed ID: 29725338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens.
    Haas KM; Johnson KL; Phipps JP; Do C
    J Immunol; 2018 Mar; 200(5):1671-1681. PubMed ID: 29374074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinated roles for glycans in regulating the inhibitory function of CD22 on B cells.
    Enterina JR; Jung J; Macauley MS
    Biomed J; 2019 Aug; 42(4):218-232. PubMed ID: 31627864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Protein Tyrosine Phosphatase SHP-1 (PTPN6) but Not CD45 (PTPRC) Is Essential for the Ligand-Mediated Regulation of CD22 in BCR-Ligated B Cells.
    Alborzian Deh Sheikh A; Akatsu C; Abdu-Allah HHM; Suganuma Y; Imamura A; Ando H; Takematsu H; Ishida H; Tsubata T
    J Immunol; 2021 Jun; 206(11):2544-2551. PubMed ID: 33990399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CD22 Inhibits Murine B Cell Receptor Activation in a Human CD22 Transgenic Mouse Model.
    Bednar KJ; Shanina E; Ballet R; Connors EP; Duan S; Juan J; Arlian BM; Kulis MD; Butcher EC; Fung-Leung WP; Rao TS; Paulson JC; Macauley MS
    J Immunol; 2017 Nov; 199(9):3116-3128. PubMed ID: 28972089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severely impaired B lymphocyte proliferation, survival, and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background.
    Poe JC; Haas KM; Uchida J; Lee Y; Fujimoto M; Tedder TF
    J Immunol; 2004 Feb; 172(4):2100-10. PubMed ID: 14764675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
    Meyer SJ; Linder AT; Brandl C; Nitschke L
    Front Immunol; 2018; 9():2820. PubMed ID: 30559744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialylated multivalent antigens engage CD22 in trans and inhibit B cell activation.
    Courtney AH; Puffer EB; Pontrello JK; Yang ZQ; Kiessling LL
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2500-5. PubMed ID: 19202057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of B cell development and B cell signalling by CD22 and its ligands alpha2,6-linked sialic acids.
    Ghosh S; Bandulet C; Nitschke L
    Int Immunol; 2006 Apr; 18(4):603-11. PubMed ID: 16497829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Linked Glycosylation Regulates CD22 Organization and Function.
    Wasim L; Buhari FHM; Yoganathan M; Sicard T; Ereño-Orbea J; Julien JP; Treanor B
    Front Immunol; 2019; 10():699. PubMed ID: 31019513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialic Acid Ligand Binding of CD22 and Siglec-G Determines Distinct B Cell Functions but Is Dispensable for B Cell Tolerance Induction.
    Özgör L; Meyer SJ; Korn M; Terörde K; Nitschke L
    J Immunol; 2018 Oct; 201(7):2107-2116. PubMed ID: 30143587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD22 is a negative regulator of B-cell receptor signalling.
    Nitschke L; Carsetti R; Ocker B; Köhler G; Lamers MC
    Curr Biol; 1997 Feb; 7(2):133-43. PubMed ID: 9016707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.
    Nitschke L
    Glycobiology; 2014 Sep; 24(9):807-17. PubMed ID: 25002414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD22 regulates adaptive and innate immune responses of B cells.
    Kawasaki N; Rademacher C; Paulson JC
    J Innate Immun; 2011; 3(4):411-9. PubMed ID: 21178327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell-dependent inhibition of B cell proliferation requires CD22.
    Santos L; Draves KE; Boton M; Grewal PK; Marth JD; Clark EA
    J Immunol; 2008 Apr; 180(7):4561-9. PubMed ID: 18354178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic antigens reveal dynamics of BCR endocytosis during inhibitory signaling.
    Courtney AH; Bennett NR; Zwick DB; Hudon J; Kiessling LL
    ACS Chem Biol; 2014 Jan; 9(1):202-10. PubMed ID: 24131142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of multifold modified sialosides as human CD22/Siglec-2 ligands with nanomolar activity on B-cells.
    Prescher H; Schweizer A; Kuhfeldt E; Nitschke L; Brossmer R
    ACS Chem Biol; 2014 Jul; 9(7):1444-50. PubMed ID: 24807582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.